Table 7 Multivariable Risk Evaluation for Recurrence and Survival
Factors | Over-all Death Risk (n = 519) | Recurrence Risk (n = 519) | ||||
|---|---|---|---|---|---|---|
| Â | Chi2 | HR (95%CI) | P | Chi2 | HR (95%CI) | P |
Gender | -0.236 | 0.790 (0.554-1.125) | 0.191 | -0.136 | 0.873 (0.629-1.213) | 0.418 |
Age | 0.446 | 1.813 (0.976-4.045) | 0.047 | 0.216 | 1.241 (0.883-1.745) | 0.213 |
BMI | -0.243 | 0.784 (0.549-1.120) | 0.181 | -0.125 | 0.882 (0.635-1.227) | 0.456 |
ASA Score | 0.236 | 1.267 (0.965-1.663) | 0.089 | 0.091 | 1.095 (0.851-1.409) | 0.481 |
Pre-op Comorbidities | 0.173 | 1.189 (0.822-1.720) | 0.359 | 0.107 | 1.113 (0.791-1.565) | 0.540 |
Tumor Location | -0.088 | 0.916 (0.809-1.036) | 0.161 | -0.062 | 0.939 (0.840-1.051) | 0.275 |
Intervention | -0.049 | 0.952 (0.871-1.041) | 0.279 | -0.030 | 0.971 (0.893-1.055) | 0.485 |
Surgical Procedures | 0.175 | 1.192 (0.833-1.706) | 0.338 | 0.018 | 1.018 (0.732-1.416) | 0.914 |
Tumor Diameter | 0.212 | 1.236 (0.858-1.781) | 0.255 | 0.280 | 1.324 (0.944-1.856) | 0.104 |
pT | 0.536 | 1.965 (0.807-12.153) | 0.049 | 0.632 | 1.533 (0.874-10.220) | 0.023 |
pN | 0.513 | 1.713 (0.647-11.584) | 0.056 | 0.576 | 1.913 (0.665-13.544) | 0.015 |
Pathological Differentiation | -0.172 | 0.842 (0.659-1.077) | 0.171 | -0.154 | 0.857 (0.683-1.075) | 0.182 |
Lymph Node Metastasis | 0.763 | 9.757 (2.186-43.546) | 0.003 | 8.280 | 20.074 (2.602-154.853) | 0.005 |
Clinical Stage | 1.354 | 3.875 (2.343-6.407) | 0.000 | 1.031 | 2.803 (1.788-4.396) | 0.000 |
Post-op Complications | -0.309 | 0.734 (0.386-1.395) | 0.345 | -0.173 | 0.841 (0.476-1.488) | 0.552 |